Skip to main content
45°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
72.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GeneDx Holdings Corp. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2024
From
GeneDx Holdings Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
January 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
GeneDx Announces Preliminary 2023 Financial Results
January 08, 2024
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Hldgs's Earnings: A Preview
October 27, 2023
Via
Benzinga
Where GeneDx Hldgs Stands With Analysts
August 09, 2023
Via
Benzinga
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
December 01, 2023
New research from one of the largest exome sequencing studies of patients with epilepsy adds to the mounting evidence that exome sequencing offers superior clinical results compared to multi-gene...
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
November 28, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
November 24, 2023
Via
Benzinga
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 20, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
November 09, 2023
The Dow Jones closed lower by around 40 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via
Benzinga
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
October 30, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023
October 09, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Earnings Scheduled For October 30, 2023
October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 28, 2023
During Thursday's session, 406 companies made new 52-week lows.
Via
Benzinga
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Announces Evolution of Executive Leadership Team
September 11, 2023
Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief of Corporate Affairs amplifying the GeneDx brand and leadership...
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
September 06, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
August 23, 2023
Wednesday's session saw 150 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 22, 2023
On Tuesday, 210 companies reached new 52-week lows.
Via
Benzinga
GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine
August 21, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
August 08, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
August 07, 2023
Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms
From
GeneDx Holdings Corp.; PacBio
Via
GlobeNewswire
GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options
July 19, 2023
Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patients
From
GeneDx Holdings Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.